Investing Profile

David Schenkein

VCInvestor
General Partner at GV
gv.com/team/david-schenkein/Boston, Massachusetts
Photo of David Schenkein, General Partner at GV (Google Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Genentech Network
75 CONNECTIONS
Xciton Biosystems, Inc. Network
64 CONNECTIONS
GV (Google Ventures) Network
56 CONNECTIONS
GV Network
47 CONNECTIONS
Wesleyan University Network
47 CONNECTIONS
cb
GV (Google Ventures) General Partner
$250K - $50.0M
$25.0M
34
$8B

Sign in to see all 18 investments on record.

Sign in with Google →
Board Member Regeneron2023 - Present
Board Member Agios Pharmaceuticals2022 - Present
General Partner GV2019 - Present
Board Member Denali Therapeutics2015 - Present
Clinical Professor of Medicine Tufts Medical Center2009 - Present
Senior Vice President, Clinical Research Xciton Biosystems, Inc.Present
Senior Vice President, Clinical Research Senti BiosciencesPresent
Clinical Professor of Medicine Tufts MedicinePresent
General Partner GV (Google Ventures)Present
Chairperson of the Board Agios Pharmaceuticals2019 - 2022
CEO Agios Pharmaceuticals2009 - 2019
Senior Vice President, Clinical Hematology/Oncology Genentech2006 - 2009
Senior Vice President, Clinical Research Millennium Pharmaceuticals2001 - 2006
Wesleyan University Bachelor of Arts (B.A.) Chemistry
Sign in with Google →
Sign in with Google →